Literature DB >> 11836262

Clinical review 141: lipids and atherosclerosis: lessons learned from randomized controlled trials of lipid lowering and other relevant studies.

Robert A Kreisberg1, Albert Oberman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11836262     DOI： 10.1210/jcem.87.2.8057

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  22 in total

1.  Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism.

Authors:  Nedret Tanaci; Derun Taner Ertugrul; Mustafa Sahin; Muammer Yucel; Irem Olcay; Nilgun Guvener Demirag; Alptekin Gursoy
Journal:  Endocrine       Date:  2006-06       Impact factor: 3.633

2.  Distribution and effect of apo E genotype on plasma lipid and apolipoprotein profiles in overweight/obese and nonobese Chinese subjects.

Authors:  Juan Zhang; Ping Fan; Rui Liu; Yi Huang; Shanshan Liang; Yu Liu; Yin Wu; Huai Bai
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

Review 3.  Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.

Authors:  Lin Jia; Jenna L Betters; Liqing Yu
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

Review 4.  Prediabetes mellitus and its links to atherosclerosis.

Authors:  Daniel Kramer; Annaswamy Raji; Jorge Plutzky
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

5.  Triptolide inhibits the progression of atherosclerosis in apolipoprotein E-/- mice.

Authors:  Longfeng Luo; Tianlun Yang
Journal:  Exp Ther Med       Date:  2016-08-24       Impact factor: 2.447

6.  Effect of the statin atorvastatin on intracellular signalling by the prostacyclin receptor in vitro and in vivo.

Authors:  Sarah J O'Meara; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2004-08-23       Impact factor: 8.739

7.  APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population.

Authors:  Rafael O Alvim; Silvia R S Freitas; Noely E Ferreira; Paulo C J L Santos; Roberto S Cunha; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  Lipids Health Dis       Date:  2010-11-08       Impact factor: 3.876

8.  Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).

Authors:  F Hartgens; G Rietjens; H A Keizer; H Kuipers; B H R Wolffenbuttel
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

9.  NPC1L1-dependent intestinal cholesterol absorption requires ganglioside GM3 in membrane microdomains.

Authors:  Wataru Nihei; Masakazu Nagafuku; Hirotaka Hayamizu; Yuta Odagiri; Yumi Tamura; Yui Kikuchi; Lucas Veillon; Hirotaka Kanoh; Kei-Ichiro Inamori; Kenta Arai; Kazuya Kabayama; Koichi Fukase; Jin-Ichi Inokuchi
Journal:  J Lipid Res       Date:  2018-09-21       Impact factor: 5.922

10.  Body fat in men with prolactinoma.

Authors:  E C O Naliato; A H D Violante; M Gaccione; D Caldas; A Lamounier Filho; C R Loureiro; R Fontes; Y Schrank; F S R Costa; A Colao
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.